Vir Biotechnology, which also plans to start human tests this summer, hired a ... The company that did the blood draws, Sanguine Biosciences, sent ...
News
- Quest for a coronavirus treatment involves door-to-door blood collection and a llama named Winter
- Departed health official says he clashed with bosses on virus
Rick Bright, who had served as the director of the Biomedical Advanced Research and Development Authority until the end of last month, disagreed ...
- Chegg, Tenet rise; Norwegian Cruise Line, WestRock fall
The biotechnology company is being bought by Alexion Pharmaceuticals for just over $1.4 billion. Norwegian Cruise Line Holdings Ltd., down $3.26 ...
- Whistleblower: US failed to prepare, sought quick virus fix
Dr. Rick Bright, former director of the Biomedical Advanced Research and Development Authority, alleges he was reassigned to a lesser role because ...
- Cerus: 1Q Earnings Snapshot
The biomedical products company posted revenue of $18.6 million in the period. Cerus expects full-year revenue in the range of $89 million to $93 ...